Efficacy of Benfluorex in Combination With Sulfonylurea in Type 2 Diabetic Patients

Abstract

Benfluorex as an add-on therapy was superior to placebo in lowering A1C with a between-group difference of 1% in type 2 diabetic patients whose disease was insufficiently controlled with sulfonylurea alone and in whom metformin was contraindicated or not tolerated.